logo
episode-header-image
Jul 2022
27m 52s

Immunai CTO and Co-Founder Luis Voloch o...

Nvidia
About this episode
What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI technology to map the human immune system and speed the development of new imm ... Show More
Up next
Yesterday
Snap’s Secret to Processing 10 Petabytes a Day: GPU-Accelerated Spark | NVIDIA AI Podcast Ep. 298
Snap processes more than 10 petabytes of experimentation data every single morning—and with NVIDIA GPU-accelerated Apache Spark on Google Cloud, Snap cut job costs by 76%, reduced memory usage by 80%, and eliminated 120 terabytes of disk spill from its pipelines. Prudhvi Vatala, ... Show More
23m 35s
May 6
Harrison Chase of LangChain on Deep Agents, LangSmith, and Earning Trust | NVIDIA AI Podcast Ep. 297
LangChain has surpassed 1 billion downloads—and the framework that started as a weekend project is now the harness powering the next generation of production-grade AI agents. In this episode, Harrison Chase, co-founder & CEO of LangChain, breaks down the architecture behind deep ... Show More
24m 54s
Apr 29
How Dassault Systèmes Is Building AI That Understands Physics - Ep. 296
Generative AI can predict whether a plane takes off—but does it know why? Nicolas Cerisier, VP of 3DEXPERIENCE Platform R&D at Dassault Systèmes, explains how industrial world models go beyond pattern recognition to embed the actual laws of physics, chemistry, and engineering. In ... Show More
23m 4s
Recommended Episodes
Jan 2018
Immune 4: Putting the immunotherapy CAR T before the cancer
<p>The immu-knowledge-ists deconstruct the holy grail of oncologists, cancer immunotherapy, and the exciting development of CAR T cells and how they work.</p> <p>Hosts: <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello" target="_blank" rel="noopener">Vincent Racaniello</a ... Show More
1h 23m
Dec 2022
HIBT Lab! Immunai: Noam Solomon
<p>According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to deve ... Show More
33m 37s
Mar 2023
How to build a virus-proof cell
00:47 An edited genetic code that prevents viral infectionResearchers have engineered bacteria with synthetic genomes to be immune to viral infection. The team streamlined the bacteria’s genetic code, and re-engineered the protein-producing machinery to insert the wrong amino aci ... Show More
31m 38s
May 2021
Robot revolution
A brain-computer interface allows a severely paralysed patient not only to move and use a robotic arm, but also to feel the sensations as the mechanical hand clasps objects . We hear from Jennifer Collinger at Pittsburgh University’s Rehab Neural Engineering Labs. And Nathan Cope ... Show More
36m 17s
Mar 2024
From Single Neurons to AI Systems: The Evolution of Decision Sciences in Medicine with Dr. Eric Horvitz
<p>In this episode of the AI Grand Rounds podcast, Dr. Eric Horvitz describes his career evolution from an interest in neurobiology to significant contributions in AI, particularly in understanding complex systems and applying AI in medicine. He discusses the shift from studying ... Show More
1h 7m
Dec 2020
The Challenges of Bringing AI into the Pharmaceutical Industry - with Kristof Szalay of Turbine.AI
Today's guest is the great and brilliant Dr. Kristof Szalay, CTO and Founder of Turbine.AI. Turbine's AI-driven platform understands cancer's inner mechanisms, enabling the discovery of novel targets & precision medicinal therapies. Episode topics include: dynamics of pharmaceuti ... Show More
17m 42s
Jul 2023
Immune 70: Immunology of picky eating
tail spinning
1h 7m
May 2024
Grant Mitchell — The Potential of AI Drug Repurposing
<p>Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing.</p> <p>Grant joins the sho ... Show More
1h 5m